The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hepatitis C Virus (HCV) Market Research Report 2025
Synopsis
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
The global Hepatitis C Virus (HCV) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.
This report aims to provide a comprehensive presentation of the global market for Hepatitis C Virus (HCV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis C Virus (HCV).
Report Scope
The Hepatitis C Virus (HCV) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis C Virus (HCV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis C Virus (HCV) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Abbott
Siemens Healthineers
Roche Diagnostics
altona Diagnostics
GeneProof
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
Nectar Lifesciences
Everlywell
bioLytical
Liferiver
3B BlackBio Biotech India Limited
Segment by Type
Hepatitis C Drugs
Hepatitis C Test Kit
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
The global Hepatitis C Virus (HCV) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.
This report aims to provide a comprehensive presentation of the global market for Hepatitis C Virus (HCV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis C Virus (HCV).
Report Scope
The Hepatitis C Virus (HCV) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis C Virus (HCV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis C Virus (HCV) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Abbott
Siemens Healthineers
Roche Diagnostics
altona Diagnostics
GeneProof
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
Nectar Lifesciences
Everlywell
bioLytical
Liferiver
3B BlackBio Biotech India Limited
Segment by Type
Hepatitis C Drugs
Hepatitis C Test Kit
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hepatitis C Drugs
1.2.3 Hepatitis C Test Kit
1.3 Market by Application
1.3.1 Global Hepatitis C Virus (HCV) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis C Virus (HCV) Market Perspective (2019-2030)
2.2 Hepatitis C Virus (HCV) Growth Trends by Region
2.2.1 Global Hepatitis C Virus (HCV) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hepatitis C Virus (HCV) Historic Market Size by Region (2019-2024)
2.2.3 Hepatitis C Virus (HCV) Forecasted Market Size by Region (2025-2030)
2.3 Hepatitis C Virus (HCV) Market Dynamics
2.3.1 Hepatitis C Virus (HCV) Industry Trends
2.3.2 Hepatitis C Virus (HCV) Market Drivers
2.3.3 Hepatitis C Virus (HCV) Market Challenges
2.3.4 Hepatitis C Virus (HCV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Virus (HCV) Players by Revenue
3.1.1 Global Top Hepatitis C Virus (HCV) Players by Revenue (2019-2024)
3.1.2 Global Hepatitis C Virus (HCV) Revenue Market Share by Players (2019-2024)
3.2 Global Hepatitis C Virus (HCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Revenue
3.4 Global Hepatitis C Virus (HCV) Market Concentration Ratio
3.4.1 Global Hepatitis C Virus (HCV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Revenue in 2023
3.5 Hepatitis C Virus (HCV) Key Players Head office and Area Served
3.6 Key Players Hepatitis C Virus (HCV) Product Solution and Service
3.7 Date of Enter into Hepatitis C Virus (HCV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Virus (HCV) Breakdown Data by Type
4.1 Global Hepatitis C Virus (HCV) Historic Market Size by Type (2019-2024)
4.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2025-2030)
5 Hepatitis C Virus (HCV) Breakdown Data by Application
5.1 Global Hepatitis C Virus (HCV) Historic Market Size by Application (2019-2024)
5.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hepatitis C Virus (HCV) Market Size (2019-2030)
6.2 North America Hepatitis C Virus (HCV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hepatitis C Virus (HCV) Market Size by Country (2019-2024)
6.4 North America Hepatitis C Virus (HCV) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hepatitis C Virus (HCV) Market Size (2019-2030)
7.2 Europe Hepatitis C Virus (HCV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hepatitis C Virus (HCV) Market Size by Country (2019-2024)
7.4 Europe Hepatitis C Virus (HCV) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size (2019-2030)
8.2 Asia-Pacific Hepatitis C Virus (HCV) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2019-2024)
8.4 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hepatitis C Virus (HCV) Market Size (2019-2030)
9.2 Latin America Hepatitis C Virus (HCV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hepatitis C Virus (HCV) Market Size by Country (2019-2024)
9.4 Latin America Hepatitis C Virus (HCV) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size (2019-2030)
10.2 Middle East & Africa Hepatitis C Virus (HCV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2019-2024)
10.4 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead
11.1.1 Gilead Company Detail
11.1.2 Gilead Business Overview
11.1.3 Gilead Hepatitis C Virus (HCV) Introduction
11.1.4 Gilead Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.1.5 Gilead Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Hepatitis C Virus (HCV) Introduction
11.2.4 Merck Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.2.5 Merck Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Hepatitis C Virus (HCV) Introduction
11.3.4 AbbVie Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 J&J
11.4.1 J&J Company Detail
11.4.2 J&J Business Overview
11.4.3 J&J Hepatitis C Virus (HCV) Introduction
11.4.4 J&J Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.4.5 J&J Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Hepatitis C Virus (HCV) Introduction
11.5.4 Bristol-Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Kawin
11.6.1 Kawin Company Detail
11.6.2 Kawin Business Overview
11.6.3 Kawin Hepatitis C Virus (HCV) Introduction
11.6.4 Kawin Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.6.5 Kawin Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Hepatitis C Virus (HCV) Introduction
11.7.4 Abbott Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.7.5 Abbott Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Detail
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers Hepatitis C Virus (HCV) Introduction
11.8.4 Siemens Healthineers Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.8.5 Siemens Healthineers Recent Development
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Detail
11.9.2 Roche Diagnostics Business Overview
11.9.3 Roche Diagnostics Hepatitis C Virus (HCV) Introduction
11.9.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.9.5 Roche Diagnostics Recent Development
11.10 altona Diagnostics
11.10.1 altona Diagnostics Company Detail
11.10.2 altona Diagnostics Business Overview
11.10.3 altona Diagnostics Hepatitis C Virus (HCV) Introduction
11.10.4 altona Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.10.5 altona Diagnostics Recent Development
11.11 GeneProof
11.11.1 GeneProof Company Detail
11.11.2 GeneProof Business Overview
11.11.3 GeneProof Hepatitis C Virus (HCV) Introduction
11.11.4 GeneProof Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.11.5 GeneProof Recent Development
11.12 Sansure Biotech
11.12.1 Sansure Biotech Company Detail
11.12.2 Sansure Biotech Business Overview
11.12.3 Sansure Biotech Hepatitis C Virus (HCV) Introduction
11.12.4 Sansure Biotech Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.12.5 Sansure Biotech Recent Development
11.13 Daan Gene
11.13.1 Daan Gene Company Detail
11.13.2 Daan Gene Business Overview
11.13.3 Daan Gene Hepatitis C Virus (HCV) Introduction
11.13.4 Daan Gene Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.13.5 Daan Gene Recent Development
11.14 BGI Group
11.14.1 BGI Group Company Detail
11.14.2 BGI Group Business Overview
11.14.3 BGI Group Hepatitis C Virus (HCV) Introduction
11.14.4 BGI Group Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.14.5 BGI Group Recent Development
11.15 Abiores
11.15.1 Abiores Company Detail
11.15.2 Abiores Business Overview
11.15.3 Abiores Hepatitis C Virus (HCV) Introduction
11.15.4 Abiores Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.15.5 Abiores Recent Development
11.16 ACON Biotech
11.16.1 ACON Biotech Company Detail
11.16.2 ACON Biotech Business Overview
11.16.3 ACON Biotech Hepatitis C Virus (HCV) Introduction
11.16.4 ACON Biotech Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.16.5 ACON Biotech Recent Development
11.17 Nectar Lifesciences
11.17.1 Nectar Lifesciences Company Detail
11.17.2 Nectar Lifesciences Business Overview
11.17.3 Nectar Lifesciences Hepatitis C Virus (HCV) Introduction
11.17.4 Nectar Lifesciences Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.17.5 Nectar Lifesciences Recent Development
11.18 Everlywell
11.18.1 Everlywell Company Detail
11.18.2 Everlywell Business Overview
11.18.3 Everlywell Hepatitis C Virus (HCV) Introduction
11.18.4 Everlywell Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.18.5 Everlywell Recent Development
11.19 bioLytical
11.19.1 bioLytical Company Detail
11.19.2 bioLytical Business Overview
11.19.3 bioLytical Hepatitis C Virus (HCV) Introduction
11.19.4 bioLytical Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.19.5 bioLytical Recent Development
11.20 Liferiver
11.20.1 Liferiver Company Detail
11.20.2 Liferiver Business Overview
11.20.3 Liferiver Hepatitis C Virus (HCV) Introduction
11.20.4 Liferiver Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.20.5 Liferiver Recent Development
11.21 3B BlackBio Biotech India Limited
11.21.1 3B BlackBio Biotech India Limited Company Detail
11.21.2 3B BlackBio Biotech India Limited Business Overview
11.21.3 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Introduction
11.21.4 3B BlackBio Biotech India Limited Revenue in Hepatitis C Virus (HCV) Business (2019-2024)
11.21.5 3B BlackBio Biotech India Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
